Veeral H Ajmera1, Norah A Terrault2, Lisa B VanWagner3, Monika Sarkar2, Cora E Lewis4, John J Carr5, Erica P Gunderson6. 1. Gastroenterology, University of California San Diego, La Jolla, CA, United States. Electronic address: v1ajmera@ucsd.edu. 2. Gastroenterology, University of California San Francisco, San Francisco, CA, United States. 3. Division of Gastroenterology & Hepatology, and Department of Preventive Medicine, Northwestern University, Chicago, IL, United States. 4. Division of Preventive Medicine, University of Alabama Birmingham, Birmingham, AL, United States. 5. Department of Radiology, Vanderbilt University, Nashville, TN, United States. 6. Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.
Abstract
BACKGROUND & AIMS: Lactation lowers blood glucose and triglycerides, and increases insulin sensitivity. We hypothesized that a longer duration of lactation would be associated with lower prevalence of non-alcoholic fatty liver disease (NAFLD), which is the leading cause of chronic liver disease in the United States. METHODS: Participants from the Coronary Artery Risk Development in Young Adults cohort study who delivered ≥ 1 child post-baseline (Y0: 1985-1986), and underwent CT quantification of hepatic steatosis 25 years following cohort entry (Y25: 2010-2011) were included (n = 844). The duration of lactation was summed for all post-baseline births, and NAFLD at Y25 was assessed by central review of CT images and defined by liver attenuation ≤ 40 Hounsfield Units after exclusion of other causes of hepatic steatosis. Unadjusted and multivariable logistic regression analyses were performed using an a priori set of confounding variables; age, race, education, and baseline body mass index. RESULTS: Of 844 women who delivered after baseline (48% black, 52% white, mean age 49 years at Y25 exam), 32% reported lactation duration of 0 to 1 month, 25% reported >1 to 6 months, 43% reported more than 6 months, while 54 (6%) had NAFLD. Longer lactation duration was inversely associated with NAFLD in unadjusted logistic regression. For women who reported >6 months lactation compared to those reporting 0-1 month, the odds ratio for NAFLD was 0.48 (95% CI 0.25-0.94; p = 0.03) and the association remained after adjustment for confounders (adjusted odds ratio 0.46; 95% CI 0.22-0.97; p = 0.04). CONCLUSIONS: A longer duration of lactation, particularly greater than 6 months, is associated with lower odds of NAFLD in mid-life and may represent a modifiable risk factor for NAFLD. LAY SUMMARY: A longer duration of breastfeeding has been associated with multiple potential health benefits for the mother including reduction in heart disease, diabetes and certain cancers. In this study we found that breastfeeding for longer than 6 months was associated with a lower risk of non-alcoholic fatty liver disease in mid-life.
BACKGROUND & AIMS:Lactation lowers blood glucose and triglycerides, and increases insulin sensitivity. We hypothesized that a longer duration of lactation would be associated with lower prevalence of non-alcoholic fatty liver disease (NAFLD), which is the leading cause of chronic liver disease in the United States. METHODS:Participants from the Coronary Artery Risk Development in Young Adults cohort study who delivered ≥ 1 child post-baseline (Y0: 1985-1986), and underwent CT quantification of hepatic steatosis 25 years following cohort entry (Y25: 2010-2011) were included (n = 844). The duration of lactation was summed for all post-baseline births, and NAFLD at Y25 was assessed by central review of CT images and defined by liver attenuation ≤ 40 Hounsfield Units after exclusion of other causes of hepatic steatosis. Unadjusted and multivariable logistic regression analyses were performed using an a priori set of confounding variables; age, race, education, and baseline body mass index. RESULTS: Of 844 women who delivered after baseline (48% black, 52% white, mean age 49 years at Y25 exam), 32% reported lactation duration of 0 to 1 month, 25% reported >1 to 6 months, 43% reported more than 6 months, while 54 (6%) had NAFLD. Longer lactation duration was inversely associated with NAFLD in unadjusted logistic regression. For women who reported >6 months lactation compared to those reporting 0-1 month, the odds ratio for NAFLD was 0.48 (95% CI 0.25-0.94; p = 0.03) and the association remained after adjustment for confounders (adjusted odds ratio 0.46; 95% CI 0.22-0.97; p = 0.04). CONCLUSIONS: A longer duration of lactation, particularly greater than 6 months, is associated with lower odds of NAFLD in mid-life and may represent a modifiable risk factor for NAFLD. LAY SUMMARY: A longer duration of breastfeeding has been associated with multiple potential health benefits for the mother including reduction in heart disease, diabetes and certain cancers. In this study we found that breastfeeding for longer than 6 months was associated with a lower risk of non-alcoholic fatty liver disease in mid-life.
Authors: Erica P Gunderson; Cora E Lewis; Gina S Wei; Rachel A Whitmer; Charles P Quesenberry; Steve Sidney Journal: Obstet Gynecol Date: 2007-03 Impact factor: 7.661
Authors: Oyekoya T Ayonrinde; Wendy H Oddy; Leon A Adams; Trevor A Mori; Lawrence J Beilin; Nicholas de Klerk; John K Olynyk Journal: J Hepatol Date: 2017-06-12 Impact factor: 25.083
Authors: Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark Journal: Am J Epidemiol Date: 2013-05-23 Impact factor: 4.897
Authors: Erica P Gunderson; Monique M Hedderson; Vicky Chiang; Yvonne Crites; David Walton; Robert A Azevedo; Gary Fox; Cathie Elmasian; Stephen Young; Nora Salvador; Michael Lum; Charles P Quesenberry; Joan C Lo; Barbara Sternfeld; Assiamira Ferrara; Joseph V Selby Journal: Diabetes Care Date: 2011-10-19 Impact factor: 19.112
Authors: Veeral H Ajmera; Erica P Gunderson; Lisa B VanWagner; Cora E Lewis; John J Carr; Norah A Terrault Journal: Am J Gastroenterol Date: 2016-03-22 Impact factor: 12.045
Authors: F P C Sijtsma; K A Meyer; L M Steffen; L Van Horn; J M Shikany; A O Odegaard; M D Gross; D Kromhout; D R Jacobs Journal: Nutr Metab Cardiovasc Dis Date: 2014-01-17 Impact factor: 4.666
Authors: Noel R Park; Halie A Taylor; Victoria A Andreasen; Ashley S Williams; Kristjan Niitepõld; Kang Nian Yap; Andreas N Kavazis; Wendy R Hood Journal: J Comp Physiol B Date: 2020-06-06 Impact factor: 2.200
Authors: Maria A Ramos-Roman; Majid M Syed-Abdul; Beverley Adams-Huet; Brian M Casey; Elizabeth J Parks Journal: Diabetes Date: 2020-05-08 Impact factor: 9.461
Authors: Ziyi Zhang; Anthony L Piro; Amina Allalou; Stacey E Alexeeff; Feihan F Dai; Erica P Gunderson; Michael B Wheeler Journal: J Clin Endocrinol Metab Date: 2022-08-18 Impact factor: 6.134
Authors: Kushala Wm Abeysekera; James G Orr; Paul Madley-Dowd; Gwen S Fernandes; Luisa Zuccolo; Fiona H Gordon; Deborah A Lawlor; Jon Heron; Matthew Hickman Journal: Lancet Reg Health Eur Date: 2021-09-05
Authors: Kathryn G Dewey; Darcy Güngör; Sharon M Donovan; Emily M Madan; Sudha Venkatramanan; Teresa A Davis; Ronald E Kleinman; Elsie M Taveras; Regan L Bailey; Rachel Novotny; Nancy Terry; Gisela Butera; Julie Obbagy; Janet de Jesus; Eve Stoody Journal: Am J Clin Nutr Date: 2021-11-08 Impact factor: 8.472
Authors: Sylvia H Ley; Jorge E Chavarro; Stefanie N Hinkle; Mengying Li; Michael Y Tsai; Frank B Hu; Cuilin Zhang Journal: BMJ Open Diabetes Res Care Date: 2020-10